Efficacy of Convalescent Plasma for the Treatment of Severe SARS-CoV-2 Infection: A Randomized, Open Label Clinical Trial

Perilla et al., NCT04391101, NCT04391101, Dec 2021
Estimated 231 patient convalescent plasma late treatment RCT with results not reported over 4 years after estimated completion.
29 convalescent plasma RCTs have results missing long after expected1-29
The trials report a total of 3,534 patients, with 15 trials having actual enrollment of 1,143, and the remainder estimated.
Perilla et al., 1 Dec 2021, Randomized Controlled Trial, Colombia, trial NCT04391101 (history). Contact: gerardoperilla@gmail.com, fabian.jaimes@udea.edu.co.
Late treatment
is less effective